OREANDA-NEWS  Elon Musk's Neuralink company will publish a study on human chipping for the first time. This is reported by Bloomberg.

The scientific article was sent to The New England Journal of Medicine. Michael Lawton, president of the Barrow Neurological Institute and the Neuralink Clinical Trials Center, said that in the material, the company's specialists talk about the first three patients who received a brain implant.

According to open data, Musk's company has already chipped 12 people. However, the company has not yet published data on its research in peer-reviewed scientific journals. The Bloomberg authors noted that outside experts will be able to independently assess the startup's success.

"Neuralink has a vision of how to use connectivity for almost anyone who might need it," Lawton emphasized. However, he believes that the company is still far from offering its services to healthy people. "Neuralink specialists have very carefully focused on patients with disabilities," the expert concluded.

At the end of September, it became known that Neuralink plans to begin clinical trials in the United States in October on a technology that allows translating human thoughts into text.